Home » Topics » Regulatory » Patents

Patents
RSS

Janssen Pharmaceutica identifies NLRP3 inflammasome inhibitors

Nov. 15, 2021

Tenova Pharmaceuticals discloses EGFR and/or ALK inhibitors

Nov. 15, 2021

Heptares Therapeutics patents histamine H4 receptor antagonists

Nov. 15, 2021

Jmackem divulges new TRPV1 antagonists

Nov. 15, 2021

BioWorld MedTech Patent Highlights: Week 44

From Current Patent Gazette

Nov. 12, 2021

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

Boehringer Ingelheim presents new HER2 inhibitors

Nov. 12, 2021

New compounds inhibiting respiratory syncytial virus identified at Janssen

Nov. 12, 2021

Roche patents potassium voltage-gated channel subfamily C member 1 activators

Nov. 12, 2021

New MAP4K1 inhibitors discovered at Wigen Biomedicine Technology

Nov. 12, 2021

PharmaMar describes HER2-targeting antibody-drug conjugates

Nov. 12, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...